Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma

LEUKEMIA

SPRINGERNATURE

1. Spanish Ministerio de Ciencia, Innovacion y Universidades [SAF2017-86126-R, RTI2018-094274-B-I00, PMP15/00007]
2. ISCIII-Sub-Directorate General for Evaluation
3. European Regional Development Fund (FEDER-Una manera de Hacer Europa)
4. National Institutes of Health, National Cancer Institute Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma [P01CA229100]
5. Generalitat de Catalunya Suport Grups de Recerca AGAUR [2017-SGR-736, 2017-SGR-1142, 2017-SGR-468]
6. Accelerator award CRUK/AIRC/AECC joint funder-partnership
7. CERCA Programme/Generalitat de Catalunya
8. CIBERONC [CB16/12/00225, CB16/12/00334, CB16/12/00489]
9. Spanish Government. EC is an Academia researcher of the Catalan Institution for Research and Advanced Studies (ICREA) [BES-2013-064328]